Related references
Note: Only part of the references are listed.Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report
Drummond E-Wen McCulloch et al.
FRONTIERS IN PHARMACOLOGY (2022)
Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
Alaina M. Jaster et al.
NEUROSCIENCE LETTERS (2022)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
Friederike Holze et al.
FRONTIERS IN PHARMACOLOGY (2021)
Investigation of the Structure-Activity Relationships of Psilocybin Analogues
Adam K. Klein et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies
Lee E. Dunlap et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists
Emil Marcher-Rorsted et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network
Adam L. Halberstadt
SCIENTIFIC REPORTS (2020)
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2020)
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim et al.
CELL (2020)
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
Friederike Holze et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice
Adam L. Halberstadt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives)
Dino Luethi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines
Karolina E. Kolaczynska et al.
FRONTIERS IN PHARMACOLOGY (2019)
Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (FLY) and benzodifuran (DragonFLY) analogs
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2019)
Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs
Landon M. Klein et al.
NEUROPHARMACOLOGY (2018)
Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
Dino Luethi et al.
NEUROPHARMACOLOGY (2018)
Long-term follow-up of psilocybin-facilitated smoking cessation
Matthew W. Johnson et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
Patrick C. Dolder et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Urinary Excretion Profiles of 2,5-Dimethoxy-4-alkylthiophenethylamine Analogs in Rats
Tatsuyuki Kanamori et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylarnine Analogues
David E. Nichols et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Receptor interaction profiles of novel N-2-methoxybenzyl (NSOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
Anna Rickli et al.
NEUROPHARMACOLOGY (2015)
Carrier-Mediated Cocaine Transport at the Blood-Brain Barrier as a Putative Mechanism in Addiction Liability
Helene Chapy et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
New phenethylamines in Europe
L. A. King
DRUG TESTING AND ANALYSIS (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2014)
Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function
Amy J. Eshleman et al.
PSYCHOPHARMACOLOGY (2014)
Coexistence of Passive and Proton Antiporter-Mediated Processes in Nicotine Transport at the Mouse Blood-Brain Barrier
Salvatore Cisternino et al.
AAPS JOURNAL (2013)
Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
Michael Kometer et al.
JOURNAL OF NEUROSCIENCE (2013)
Characterization of the head-twitch response induced by hallucinogens in mice Detection of the behavior based on the dynamics of head movement
Adam L. Halberstadt et al.
PSYCHOPHARMACOLOGY (2013)
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model
Clint E. Canal et al.
DRUG TESTING AND ANALYSIS (2012)
Prediction of Psilocybin Response in Healthy Volunteers
Erich Studerus et al.
PLOS ONE (2012)
G Protein- and Agonist-Bound Serotonin 5-HT2A Receptor Model Activated by Steered Molecular Dynamics Simulations
Vignir Isberg et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
Adam L. Halberstadt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
A Medicinal Chemist's Guide to Molecular Interactions
Caterina Bissantz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Differential Effects of Serotonin 5-HT1A Receptor Agonists on the Discriminative Stimulus Effects of the 5-HT2A Receptor Agonist 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rats and Rhesus Monkeys
Jun-Xu Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Interaction of 5-HT2A and 5-HT2C Receptors in R(-)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice
W. E. Fantegrossi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs
Pascal Andre et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Discriminative stimulus effects of 1-(2,5-dimethoxy-4methylphenyl)-2-aminopropane in rhesus monkeys
Jun-Xu Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Assessment of the roles of serines 5.43(239) and 5.46(242) for binding and potency of agonist ligands at the human serotonin 5-HT2A receptor
Michael R. Braden et al.
MOLECULAR PHARMACOLOGY (2007)
In vivo metabolism of 2,5-dimethoxy-4-propylthiophenethylamine in rat
T. Kanamori et al.
XENOBIOTICA (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists
Michael R. Braden et al.
MOLECULAR PHARMACOLOGY (2006)
New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic')
F Schifano et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Interfaces and the driving force of hydrophobic assembly
D Chandler
NATURE (2005)
New designer drug 2,5-dimethoxy-4-ethylthio-β-phenethylamine (2C-T-2):: studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry
DS Theobald et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats
WE Fantegrossi et al.
PSYCHOPHARMACOLOGY (2005)
New designer drug, 2,5-dimethoxy-4-propylthio-beta-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography mass spectrometry
DS Theobald et al.
JOURNAL OF MASS SPECTROMETRY (2005)
A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs
D de Boer et al.
PHARMACY WORLD & SCIENCE (2004)
Stimulus effects of three sulfur-containing psychoactive agents
N Khorana et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propylthiophenethylamine using GG-MSD and GC-NPD
B Curtis et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2003)
A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor
JJ Chambers et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2002)
Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists
SP Vickers et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
1-[4-(3-phenylalkyl)phenyl]-2-aminopropanes as 5-HT2A partial agonists
CS Dowd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
